Altered expression of lysosomal hydrolase, acid α-glucosidase, gene in coronary artery disease
Related Experiment Video
Updated: Mar 30, 2026

Calcification of Vascular Smooth Muscle Cells and Imaging of Aortic Calcification and Inflammation
Published on: May 31, 2016
Jingyi Zhang1, Ling Ma, Junping Zhang
1aCollege of Clinical Medicine, Xinxiang Medical University, Xinxiang, Henan bDivision of Cardiology cShandong Provincial Key Laboratory of Cardiac Disease Diagnosis and Treatment, Affiliated Hospital of Jining Medical University, Jining Medical University, Shandong, China.
Insights
Gene expression of acid α-glucosidase (GAA) is significantly increased in coronary artery disease (CAD) patients. This suggests a potential role for GAA in the development of atherosclerosis and CAD.
Area of Science:
- Biochemistry
- Molecular Biology
- Cardiovascular Disease Research
Background:
- Coronary artery disease (CAD) is a complex condition driven by atherosclerosis.
- Autophagy, a cellular process involving lysosomes, plays a role in lipid and cholesterol metabolism.
- Previous studies indicated altered expression of autophagic and lysosomal genes in CAD patients.
Purpose of the Study:
- To investigate the gene expression of acid α-glucosidase (GAA), a lysosomal hydrolase, in patients with CAD.
- To compare GAA expression levels between CAD patients and ethnically matched controls.
Main Methods:
- Examined GAA gene expression in large cohorts of CAD patients (n=248) and controls (n=208).
- Assessed GAA enzymatic activity, protein levels, and transcript levels.
- Utilized multivariate logistic regression analysis including GAA transcript level, hypertension, diabetes, and smoking.
Main Results:
- GAA enzymatic activity and transcription levels were significantly elevated in CAD patients compared to controls (P<0.05 and P<0.01, respectively).
- GAA transcript levels showed a strong association with CAD (odds ratio 5.93, P=3.89×10(-7)).
- GAA protein levels showed an insignificant increase in CAD patients, potentially due to assay limitations.
Conclusions:
- GAA gene expression is significantly increased in CAD patients.
- These findings suggest that GAA may play a role in the pathogenesis of coronary artery disease.
Background:
Coronary artery disease (CAD) is a common complex disease caused by atherosclerosis. Autophagy is a cellular degradation process that delivers long-lived macromolecules and dysfunctional organelles into lysosomes for digestion. Autophagy regulates lipid and cholesterol metabolism. We have previously shown that expression of autophagic and lysosomal genes is altered in CAD patients. In this study, we investigated gene expression of a lysosomal hydrolase, acid α-glucosidase (GAA), in CAD patients and controls.
Methods:
GAA gene expression was examined in large cohorts of CAD patients (n=248) and ethnically matched controls (n=208). GAA enzymatic activity, protein levels, and transcript levels were determined and compared between CAD patients and controls.
Results:
GAA activities in CAD patients were significantly elevated (P<0.05) compared with controls. Consistently, GAA transcription levels were also significantly increased in CAD patients (P<0.01). Multivariate logistic regression analyses (GAA transcript level, hypertension, diabetes, and smoking) revealed that GAA transcript levels were strongly associated with CAD (odds ratio 5.93, 95% confidence interval 2.98-11.78, P=3.89×10(-7)). GAA protein levels were insignificantly increased in CAD patients (P>0.05), likely due to assay insensitivity.
Conclusion:
Compared with controls, GAA gene expression levels in CAD patients were significantly increased, suggesting that GAA may be involved in the CAD development.
More Related Videos
11:00A Model of Disturbed Flow-Induced Atherosclerosis in Mouse Carotid Artery by Partial Ligation and a Simple Method of RNA Isolation from Carotid Endothelium
Published on: June 22, 2010
08:22Isolation of Endocardial and Coronary Endothelial Cells from the Ventricular Free Wall of the Rat Heart
Published on: April 15, 2020
Related Concept Videos
Lysosomal Hydrolases
Coronary Artery Disease II: Pathophysiology
Pharmacogenomics: Identification of New Drug Targets